UPDATE: Dahlman Rose Reiterates Buy Rating, Raises PT on Eastman Chemical Company

In a report published Monday, Dahlman Rose & Co. reiterated its Buy rating on Eastman Chemical Company

, and raised its price target to $75.00. Dahlman Rose noted, “We believe that EMN's acquisition will ultimately prove to be far more valuable than can be gleaned from the advertised synergies and purchased earnings as EMN uses its own market access and technological expertise to significantly expand Solutia offerings and vice versa. The company laid out specific examples of how the two entities have combined to offer new and better products that might not exist without the combination. We believe this is the way to get value from an acquisition as opposed to simply buying earnings and cutting costs. To us, shareholder value is more strongly driven by how the acquisition can outperform the sum of its parts.” Eastman Chemical Company closed on Friday at $64.68.